Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children
Top Cited Papers
- 13 September 2012
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 367 (11) , 1012-1019
- https://doi.org/10.1056/nejmoa1200850
Abstract
In the United States, children receive five doses of diphtheria, tetanus, and acellular pertussis (DTaP) vaccine before 7 years of age. The duration of protection after five doses of DTaP is unknown.Keywords
This publication has 19 references indexed in Scilit:
- Imperfect vaccine-induced immunity and whooping cough transmission to infantsVaccine, 2010
- The Present and Future Control of PertussisClinical Infectious Diseases, 2010
- A New Method for Estimating Race/Ethnicity and Associated Disparities Where Administrative Records Lack Self‐Reported Race/EthnicityHealth Services Research, 2008
- Case-Control Study of Vaccination History in Relation to Pertussis Risk During an Outbreak Among School StudentsThe Pediatric Infectious Disease Journal, 2006
- Long-term Follow-up of Swedish Children Vaccinated With Acellular Pertussis Vaccines at 3, 5, and 12 Months of Age Indicates the Need for a Booster Dose at 5 to 7 Years of AgePediatrics, 2006
- Prevention of Pertussis Among Adolescents: Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) VaccinePediatrics, 2006
- Sustained Efficacy During the First 6 Years of Life of 3-Component Acellular Pertussis Vaccines Administered in Infancy: The Italian ExperiencePediatrics, 2001
- Changing Epidemiology of Pertussis in the United States: Increasing Reported Incidence Among Adolescents and Adults, 1990‐1996Clinical Infectious Diseases, 1999
- Epidemiological Features of Pertussis in the United States, 1980-1989Clinical Infectious Diseases, 1992
- An Evaluation of Pertussis VaccineClinical Infectious Diseases, 1979